Endocrinology, Vol 136, 2013-2021, Copyright © 1995 by Endocrine Society

ARTICLES

Number and size of islets of Langerhans in pregnant, human growth hormone-expressing transgenic, and pituitary dwarf mice: effect of lactogenic hormones

JA Parsons, A Bartke and RL Sorenson
Department of Cell Biology and Neuroanatomy, University of Minnesota Medical School, Minneapolis 55455, USA.

To determine the effects of lactogenic hormones on pancreatic islet size and numbers, islets of 3-month-old female mice were intravitally stained by an ip injection of an alkaline-alcohol solution of diphenylthiocarbazone (dithizone; 100 micrograms/g BW). After 15 min, animals were killed, and pancreases were removed, diced, cleared in glycerol, and whole mounted on slides. Major and minor axes of Zn dithizoate-stained islets were measured at x40 magnification. Islet areas and volumes were calculated. Animals and appropriate controls studied included 16-day pregnant, two lines of human GH-expressing transgenic, and two lines of pituitary PRL- and GH-deficient dwarf mice. Islet numbers per pancreas ranged from about 500-1200 in all groups except the transgenic mice, in which two of five animals in one group and one of five in the other showed significant increases in islet numbers (> 3 x SD control mean). In all cases, significant (P < 0.05) changes in both islet area and volume occurred. Area increased 2- fold in both pregnant and transgenic mice and decreased by a similar amount in dwarf mice. Islet volume increased 2- and 3-fold in pregnant and transgenic animals, respectively, and decreased 2- to 5-fold in dwarf mice. Analysis of the distributions of islet sizes revealed that almost all of the volume increases in the pregnant and transgenic mice and the decreases in dwarf mice were accounted for by alterations in the numbers and sizes of large (diameter, > 150 microns) islets. Our results with dwarf mice show that maintenance of islet numbers is not dependent upon pituitary PRL or GH; however, results with transgenic mice suggest that prolonged high levels of lactogens may induce islet neogenesis. The islet area and volume results for all of the mice studied support the hypothesis that lactogenic hormones are potent regulators of islet mass.

This article has been cited by other articles:

				R. Arumugam, E. Horowitz, D. Lu, J. J. Collier, S. Ronnebaum, D. Fleenor, and M. Freemark The Interplay of Prolactin and the Glucocorticoids in the Regulation of {beta}-Cell Gene Expression, Fatty Acid Oxidation, and Glucose-Stimulated Insulin Secretion: Implications for Carbohydrate Metabolism in Pregnancy Endocrinology, November 1, 2008; 149(11): 5401 - 5414. [Abstract] [Full Text] [PDF]

				T C. Brelje, N. V Bhagroo, L. E Stout, and R. L Sorenson Beneficial effects of lipids and prolactin on insulin secretion and {beta}-cell proliferation: a role for lipids in the adaptation of islets to pregnancy J. Endocrinol., May 1, 2008; 197(2): 265 - 276. [Abstract] [Full Text] [PDF]

				M. Zhao, S. A Amiel, M. R Christie, P. Muiesan, P. Srinivasan, W. Littlejohn, M. Rela, M. Arno, N. Heaton, and G. C. Huang Evidence for the presence of stem cell-like progenitor cells in human adult pancreas J. Endocrinol., December 1, 2007; 195(3): 407 - 414. [Abstract] [Full Text] [PDF]

				J. Jo, M. Y. Choi, and D.-S. Koh Size Distribution of Mouse Langerhans Islets Biophys. J., October 15, 2007; 93(8): 2655 - 2666. [Abstract] [Full Text] [PDF]

				A. J Weinhaus, L. E Stout, N. V Bhagroo, T C. Brelje, and R. L Sorenson Regulation of glucokinase in pancreatic islets by prolactin: a mechanism for increasing glucose-stimulated insulin secretion during pregnancy J. Endocrinol., June 1, 2007; 193(3): 367 - 381. [Abstract] [Full Text] [PDF]

				A. S. Narang and R. I. Mahato Biological and biomaterial approaches for improved islet transplantation. Pharmacol. Rev., June 1, 2006; 58(2): 194 - 243. [Abstract] [Full Text] [PDF]

				B. L. Stiles, C. Kuralwalla-Martinez, W. Guo, C. Gregorian, Y. Wang, J. Tian, M. A. Magnuson, and H. Wu Selective Deletion of Pten in Pancreatic {beta} Cells Leads to Increased Islet Mass and Resistance to STZ-Induced Diabetes. Mol. Cell. Biol., April 1, 2006; 26(7): 2772 - 2781. [Abstract] [Full Text] [PDF]

				A. M. Holland, L. J. Gonez, G. Naselli, R. J. MacDonald, and L. C. Harrison Conditional Expression Demonstrates the Role of the Homeodomain Transcription Factor Pdx1 in Maintenance and Regeneration of {beta}-Cells in the Adult Pancreas Diabetes, September 1, 2005; 54(9): 2586 - 2595. [Abstract] [Full Text] [PDF]

				A. Bartke Minireview: Role of the Growth Hormone/Insulin-Like Growth Factor System in Mammalian Aging Endocrinology, September 1, 2005; 146(9): 3718 - 3723. [Abstract] [Full Text] [PDF]

				Y. Guo, Y. Lu, D. Houle, K. Robertson, Z. Tang, J. J. Kopchick, Y. L. Liu, and J.-L. Liu Pancreatic Islet-Specific Expression of an Insulin-Like Growth Factor-I Transgene Compensates Islet Cell Growth in Growth Hormone Receptor Gene-Deficient Mice Endocrinology, June 1, 2005; 146(6): 2602 - 2609. [Abstract] [Full Text] [PDF]

				T. C. Brelje, L. E. Stout, N. V. Bhagroo, and R. L. Sorenson Distinctive Roles for Prolactin and Growth Hormone in the Activation of Signal Transducer and Activator of Transcription 5 in Pancreatic Islets of Langerhans Endocrinology, September 1, 2004; 145(9): 4162 - 4175. [Abstract] [Full Text] [PDF]

				K. H. Yoon, S. H. Ko, J. H. Cho, J. M. Lee, Y. B. Ahn, K. H. Song, S. J. Yoo, M. I. Kang, B. Y. Cha, K. W. Lee, et al. Selective {beta}-Cell Loss and {alpha}-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2300 - 2308. [Abstract] [Full Text] [PDF]

				M. Freemark, I. Avril, D. Fleenor, P. Driscoll, A. Petro, E. Opara, W. Kendall, J. Oden, S. Bridges, N. Binart, et al. Targeted Deletion of the PRL Receptor: Effects on Islet Development, Insulin Production, and Glucose Tolerance Endocrinology, April 1, 2002; 143(4): 1378 - 1385. [Abstract] [Full Text] [PDF]

				T. C. Brelje, A. M. Svensson, L. E. Stout, N. V. Bhagroo, and R. L. Sorenson An Immunohistochemical Approach to Monitor the Prolactin-induced Activation of the JAK2/STAT5 Pathway in Pancreatic Islets of Langerhans J. Histochem. Cytochem., March 1, 2002; 50(3): 365 - 383. [Abstract] [Full Text] [PDF]

				A. Moore, S. Bonner-Weir, and R. Weissleder Noninvasive In Vivo Measurement of {beta}-Cell Mass in Mouse Model of Diabetes Diabetes, October 1, 2001; 50(10): 2231 - 2236. [Abstract] [Full Text]

				M. Skau, B. Pakkenberg, K. Buschard, and T. Bock Linear Correlation Between the Total Islet Mass and the Volume-Weighted Mean Islet Volume Diabetes, August 1, 2001; 50(8): 1763 - 1770. [Abstract] [Full Text] [PDF]

				S. Bonner-Weir Perspective: Postnatal Pancreatic {beta} Cell Growth Endocrinology, June 1, 2000; 141(6): 1926 - 1929. [Full Text] [PDF]

				B. Blondeau, A. Garofano, P. Czernichow, and B. Bréant Age-Dependent Inability of the Endocrine Pancreas to Adapt to Pregnancy: A Long-Term Consequence of Perinatal Malnutrition in the Rat Endocrinology, September 1, 1999; 140(9): 4208 - 4213. [Abstract] [Full Text]

				L. E. Stout, A. M. Svensson, and R. L. Sorenson Prolactin Regulation of Islet-Derived INS-1 Cells: Characteristics and Immunocytochemical Analysis of STAT5 Translocation Endocrinology, April 1, 1997; 138(4): 1592 - 1603. [Abstract] [Full Text] [PDF]

				R. C. Vasavada, C. Cavaliere, A. J. D'Ercole, P. Dann, W. J. Burtis, A. L. Madlener, K. Zawalich, W. Zawalich, W. Philbrick, and A. F. Stewart Overexpression of Parathyroid Hormone-related Protein in the Pancreatic Islets of Transgenic Mice Causes Islet Hyperplasia, Hyperinsulinemia, and Hypoglycemia J. Biol. Chem., January 12, 1996; 271(2): 1200 - 1208. [Abstract] [Full Text] [PDF]